Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
10.00
+0.72 (7.82%)
Apr 17, 2025, 2:50 PM EDT - Market open

COEP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
341127302,494338
Upgrade
Market Cap Growth
-57.71%-57.71%-10.53%-98.80%637.84%-
Upgrade
Enterprise Value
351226262,497338
Upgrade
Last Close Price
10.005.5015.6830.63200.00203.80
Upgrade
PS Ratio
----33258.2310990.00
Upgrade
PB Ratio
6.642.9232.856.711061.15-65.73
Upgrade
P/TBV Ratio
12.734.2832.856.711061.15-
Upgrade
EV/Sales Ratio
----33296.4410981.90
Upgrade
Debt / Equity Ratio
0.360.361.500.461.74-0.41
Upgrade
Asset Turnover
----0.020.03
Upgrade
Quick Ratio
0.120.120.511.750.790.04
Upgrade
Current Ratio
0.230.230.591.810.790.04
Upgrade
Return on Equity (ROE)
-464.73%-464.73%-807.49%-1104.48%--
Upgrade
Return on Assets (ROA)
-93.24%-93.24%-215.14%-291.15%-248.47%-451.53%
Upgrade
Return on Capital (ROIC)
-172.06%-172.06%-314.28%-330.28%-519.93%-
Upgrade
Earnings Yield
-2916.43%-86.79%-79.54%-125.73%-0.54%-2.71%
Upgrade
FCF Yield
-1976.05%-58.80%-27.08%-12.97%-0.18%-0.93%
Upgrade
Buyback Yield / Dilution
-4983.60%-49.84%-79.70%-30.98%-79.11%-18.53%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q